Detalhe da pesquisa
1.
Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?
Pharmacol Res
; 196: 106924, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37709185
2.
Curcumin: A therapeutic strategy for colorectal cancer?
Semin Cancer Biol
; 73: 321-330, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32942023
3.
Curcumin: A Novel Way to Improve Quality of Life for Colorectal Cancer Patients?
Int J Mol Sci
; 23(22)2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430537
4.
Hypoxia: The Cornerstone of Glioblastoma.
Int J Mol Sci
; 22(22)2021 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830491
5.
Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer.
Int J Mol Sci
; 19(10)2018 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30347758
6.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Br J Cancer
; 117(12): 1777-1786, 2017 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123263
7.
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer.
Gastroenterology
; 151(5): 961-972, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521480
8.
LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET.
Mol Carcinog
; 55(5): 411-9, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25647613
9.
EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report.
Oral Oncol
; 146: 106543, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573683
10.
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data.
Breast
; 62: 1-9, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078146
11.
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Eur Urol
; 79(6): 722-733, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33153817
12.
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines.
Mol Cancer Ther
; 8(4): 771-8, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19372549
13.
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer.
Mol Cancer Ther
; 8(1): 194-202, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139129
14.
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy.
Int J Cancer
; 124(12): 2905-10, 2009 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19296535
15.
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.
Cancers (Basel)
; 11(10)2019 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31614664
16.
The European Network for Sinonasal Cancer Research (EUSICA) - A pan-European initiative targeting a group of orphan tumours.
Eur J Cancer
; 202: 113939, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447380
17.
Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer.
Eur J Cancer
; 44(9): 1229-37, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18448328
18.
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
World J Gastroenterol
; 24(42): 4738-4749, 2018 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30479461
19.
Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan.
Oncol Rep
; 17(3): 637-45, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17273745
20.
Editorial: Transcriptional Regulation as a Key Player in Cancer Cells Drug Resistance.
Front Oncol
; 11: 764506, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34765559